USPTO serial 79358759
SURGE
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- DWYER, JOHN D
- Law office
- TMO LAW OFFICE 116
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SURGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel Lano
Daniel Lano IpHorgan Ltd.195 Arlington Heights RoadSuite 125Buffalo Grove, IL 60089Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable or recorded artificial intelligence computer programs in the field of medical diagnostics to identify patients at risk of a clinical outcome; downloadable Software as a Medical Device [SaMD] for analyzing medical data to identify patients at risk of a clinical outcome; data processing programs in the medical field, namely, downloadable or recorded programs to identify patients at risk of a clinical outcome; vials for laboratories being laboratory glassware, for collection and/or blood stimulation | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical use, namely blood sample kit; Medical apparatus and instruments namely to identify patients at risk of a clinical outcomes, namely blood sample kit; in-vitro diagnostic medical devices, namely medical diagnostic apparatus for testing to identify clinical outcome and/or risk factors for complications during surgery | ACTIVE | — |
| 035 | Collection, compilation and systematization of information into computer databases in the field of pharmaceutical research and development, medicine and clinical trials; database management in the field of pharmaceutical research and development, medicine and clinical trials; compilation of statistics for business purposes in the field of health and medicine; collection and systemization of information into computer databases in the field of pharmaceutical, health and medical research and development; public relations in the field of health and medicine | ACTIVE | — |
| 042 | Software design and development in the field of pharmaceutical, health and medical research to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; providing information with respect to medical research in the field of pharmaceutical products and medical devices to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; medical and scientific research namely, conducting clinical trials for others relating to pharmaceutical products and medical devices, namely to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; scientific and technological services, namely, scientific research with respect to medicine to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; bio-informatic, chemical and biological analysis to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; scientific research in the fields of chemistry, biology, bacteriology, nutrition, biotechnology to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; product research and development services in the field of immunology to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway; Software as a Service [SaaS] in the medical and health fields used to provide an accurate prediction of clinical outcome and/or surgical complications to aid surgical decision-making and enable the optimization of individual patient's' perioperative care pathway | ACTIVE | — |
| 044 | Provision of medical information services; providing medical information; medical services and medical services in the field of surgery; pharmaceutical services, namely, pharmaceutical research services; pharmaceutical consultation; information and advisory services relating to pharmaceutical products, namely pharmaceutical advice and providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; telemedicine services; medical assistance; remote medical assistance; advice in connection with dietetics and nutrition; providing information relating to nutrition; wellness services being health and nutrition counseling; preparation of psychological profiles for medical purposes, namely psychological testing for medical purposes; professional consultancy in the field of medical technology, medical surgery and orthopedics, namely, medical consultation; remote monitoring of medical data for medical diagnosis and treatment purposes; medical and surgical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; alternative medicine services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 16, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 15, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 13, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 30, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 7, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 20, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 20, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 20, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 27, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 26, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 26, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 22, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 23, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 23, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 18, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 17, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 29, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |